Baxter International EBIT

Baxter International (BTL.DE) currently reports a EBIT of $470M as of September 2026. That compares with $-230M in the prior-year period — up 300.4% year over year. That is below the Healthcare sector average of $130B. Use the charts on this page to explore Baxter International's EBIT history and peer comparisons.

Baxter International's EBIT increased from $-230M to $470M — a 300.4% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Baxter International's EBIT of $470M is lower than the Healthcare sector average of $130B. That is roughly 99.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Baxter International reported $470M in EBIT as of September 2026. That compares with $-230M in the prior-year period — up 300.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $470M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $130B. From there, open related valuation or income-statement pages for Baxter International, and consider following BTL.DE for alerts when major investors trade the stock.